Mettrum is a Health Canada licensed producer of medicinal cannabis and is committed to ongoing research, regulatory compliance, producing quality products, and providing comprehensive customer service.
Mettrum provides doctor-prescribed patients with trusted and reliable access to pharmaceutical grade medical cannabis, Mettrum is proud to provide you with a natural option to help improve your quality of life.
Invest In MJ Charts:
Q2 2016 versus Q1 2016 Financial Highlights:
- Revenues increases 36% to $1,711,072
- Gross Margin increases 42% to $971,237
- Grams sold increases 32% to 211,730 grams
TORONTO, ONTARIO--(Marketwired - Nov. 11, 2015) - Mettrum Health Corp. ("Mettrum" or the "Company") (TSX VENTURE:MT), a vertically integrated health and wellness company focused on research, development, production and distribution of cannabis products, announced today its second quarter fiscal 2016 financial results for the period ended September 30, 2015.
For the second quarter ended September 30, 2015, Mettrum revenues increased 36 percent to $1,711,072 primarily on 211,730 grams of medical cannabis sold, versus $1,249,171 on 160,560 grams of medical cannabis sold the previous quarter. Average selling price per gram increased to $7.72 from $7.45 in the prior quarter. Gross margin also increased by 42 percent to $971,237, from $686,124 during the previous quarter. On a per gram basis the gross margins increased to $4.49 per gram for the quarter ended September 30, 2015 versus $4.20 per gram for the quarter ended June 30, 2015. EBITDA loss, Loss from operations, net loss and loss per share amounted to $1,622,121, $2,081,362, $2,083,072 and $0.06 per share, respectively.
Figures in CDN $ | For the three months ended September 30, 2015 |
For the three months ended June 30, 2015 |
For the three months ended September 30, 2014 |
|||
Grams sold | 211,730 | 160,560 | 108,285 | |||
Revenue | 1,711,072 | 1,249,171 | 806,412 | |||
Gross margin | 971,237 | 686,124 | 255,922 | |||
Operating expenses | 3,054,309 | 2,642,491 | 2,076,083 | |||
EBITDA | (1,622,121 | ) | (1,611,861 | ) | (1,680,304 | ) |
Loss from operations | (2,081,362 | ) | (1,956,367 | ) | (1,820,161 | ) |
Net loss | (2,083,072 | ) | (1,913,948 | ) | (2,786,530 | ) |
Net loss per share basic and diluted | (0.06 | ) | (0.06 | ) | (0.14 | ) |
As at September 30, 2015, the Company maintained a solid balance sheet with a net cash position of approximately $11.3 million.
Financial and Operational Highlights
"Our products and marketing platforms continue to grow revenues as well as our overall customer base," noted Michael Haines, CEO of Mettrum. "Taking a long term view, we continued to invest in our facilities to improve quality, yields and margins. We expect to see the results of these investments manifest throughout the balance of our fiscal year and beyond. We are excited about the significant growth across our entire business, including the recently launched Mettrum Originals hemp food line. We look forward to further accelerating our growth and reporting our successes to our stakeholders in the coming quarters."